Fatal delayed thrombocytopenia following abciximab therapy.
McCorry
Roger B
RB
Department of Cardiology, Royal Victoria Hospital, Belfast, United Kingdom.
Johnston
Paul
P
D000077284:Abciximab; D000328:Adult; D017130:Angioplasty; D000911:Antibodies, Monoclonal / Q000009:adverse effects*; D002637:Chest Pain / Q000188:drug therapy; D003324:Coronary Artery Disease / Q000188:drug therapy*; D017809:Fatal Outcome; D006801:Humans; D007140:Immunoglobulin Fab Fragments / Q000009:adverse effects*; D008297:Male; D010975:Platelet Aggregation Inhibitors / Q000009:adverse effects*; D010976:Platelet Count; D013921:Thrombocytopenia / Q000139:chemically induced* / Q000175:diagnosis; D013997:Time Factors
D000911:Antibodies, Monoclonal; D007140:Immunoglobulin Fab Fragments; D010975:Platelet Aggregation Inhibitors; D000077284:Abciximab